✦ LIBER ✦

Combination regimen active in advanced adrenocortical cancer

Book ID: 120874277
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1999
Weight: 269 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199911700-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel regimen active in advanced ga

Paclitaxel regimen active in advanced gastric cancer

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 172 KB

Docetaxel regimen active in advanced gas

Docetaxel regimen active in advanced gastric cancer

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Oxaliplatin regimen active in advanced c

Oxaliplatin regimen active in advanced colorectal cancer

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 251 KB

Modified CMF regimen active in advanced

Modified CMF regimen active in advanced breast cancer

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 114 KB

Comparison Of Two Combination Chemothera

Comparison Of Two Combination Chemotherapy Regimens In Advanced Colorectal Cancer

✍ A. A. Epenetos, C. Amos, C. Collis, M. Slevin, A. Rohatiner, H. Baille-Johnson, 📂 Article 📅 1980 🏛 BMJ Publishing Group 🌐 English ⚖ 493 KB

Combination chemotherapy for advanced br

Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin

✍ Gerard T. Kennealey; Barry Boston; Malcolm S. Mitchell; Mary Kathryn Knobf; Samu 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Forty-eight women with advanced metastatic carcinoma of the breast were treated with one of two combination chemotherapy regimens: 1) adriamycin and cyclophosphamide or 2) adriamycin, cyclophosphamide, methotrexate and 5-fluorouracil. The response rate in the two-drug treatment group was 50% and in